Chinook Therapeutics Inc Cvr (ADRO)
SG&A Expense Growth
-3.44%
Fiscal year · Period ending:
ADRO SG&A Expense Growth
Latest reported-3.44%period ending
Latest reported-3.44%period ending
ADRO FY SG&A Growth (YoY) (0.00% → -3.44%)
Latest values, visible window
High-resolution chart · PNG
ADRO sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -3.4411% | |
| 6.7672% | |
| -1.5346% | |
| 23.2764% | |
| 209.1505% | |
| 92.3028% | |
| 0% |